Tag: ibuprofen

Articles

• Aspirin and breast cancer
• Morphine during surgery might increase risk of metastasis

News

04/18/15

Aspirin reduces growth and self-renewal capacity of BC stem cells

11/21/11

Use of NSAIDs before diagnosis does not improve BC survival

04/28/11

Aspirin linked to reduced BC risk, but ibuprofen may increase it

Studies

• Toxic, Genotoxic and Teratogenic Effects of Ibuprofen and its Derivatives Cite
  Yılmaz S, Çalışıcı D, Goktas B. Toxic, Genotoxic and Teratogenic Effects of Ibuprofen and its Derivatives. Current Drug Targets. Bentham Science Publishers Ltd.; 2023; 24:361-370 10.2174/1389450124666230104160435
• Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors Cite
  Choi E, Lee J, Wu JT, Wakelee HA, Schapira L, Kurian AW, et al. Abstract P055: Risk factors for second primary lung cancer among breast cancer survivors. Cancer Prevention Research. American Association for Cancer Research (AACR); 2023; 16:P055-P055 10.1158/1940-6215.precprev22-p055
• Medication use and mammographic breast density Cite
  Han Y, Lee CT, Xu S, Mi X, Phillip CR, Salazar AS, et al. Medication use and mammographic breast density. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2021; 10.1007/s10549-021-06321-5
• Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease Cite
  Degnim A, Vierkant R, Winham S, Frost M, Visscher D, Carter J, et al. Abstract P5-08-06: NSAID use and breast cancer risk in a retrospective cohort of women with benign breast disease. Poster Session Abstracts. American Association for Cancer Research; 2020; 10.1158/1538-7445.sabcs19-p5-08-06
• Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer Cite
  Pennock ND, Martinson HA, Guo Q, Betts CB, Jindal S, Tsujikawa T, et al. Ibuprofen supports macrophage differentiation, T cell recruitment, and tumor suppression in a model of postpartum breast cancer. Journal for ImmunoTherapy of Cancer. BMJ; 2018; 6 10.1186/s40425-018-0406-y
• Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals Cite
  Dandah O, Najafzadeh M, Isreb M, Linforth R, Tait C, Baumgartner A, et al. Aspirin and ibuprofen, in bulk and nanoforms: Effects on DNA damage in peripheral lymphocytes from breast cancer patients and healthy individuals. Mutation Research/Genetic Toxicology and Environmental Mutagenesis. Elsevier BV; 2018; 826:41-46 10.1016/j.mrgentox.2017.12.001
• Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis Cite
  de Pedro M, Baeza S, Escudero M, Dierssen-Sotos T, Gómez-Acebo I, Pollán M, et al. Effect of COX-2 inhibitors and other non-steroidal inflammatory drugs on breast cancer risk: a meta-analysis. Breast Cancer Research and Treatment. Springer Science and Business Media LLC; 2015; 149:525-536 10.1007/s10549-015-3267-9
• Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study. Cancer Causes & Control. Springer Science and Business Media LLC; 2010; 21:1503-1512 10.1007/s10552-010-9579-5
• NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals Cite
  Kodela R, Chattopadhyay M, Kashfi K. NOSH-Aspirin: A Novel Nitric Oxide–Hydrogen Sulfide-Releasing Hybrid: A New Class of Anti-inflammatory Pharmaceuticals. ACS Medicinal Chemistry Letters. American Chemical Society (ACS); 2012; 3:257-262 10.1021/ml300002m
• Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis Cite
  Li Y, Brasky TM, Nie J, Ambrosone CB, McCann SE, Shields PG, et al. Use of Nonsteroidal Anti-inflammatory Drugs and Survival Following Breast Cancer Diagnosis. Cancer Epidemiology Biomarkers & Prevention. American Association for Cancer Research (AACR); 2011; 21:239-242 10.1158/1055-9965.epi-11-1012
• Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype Cite
  Brasky TM, Bonner MR, Moysich KB, Ambrosone CB, Nie J, Tao MH, et al. Non-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype. Cancer Causes & Control. Springer Science and Business Media LLC; 2011; 22:965-975 10.1007/s10552-011-9769-9
• Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis Cite
  Forget P, Vandenhende J, Berliere M, Machiels J, Nussbaum B, Legrand C, et al. Do Intraoperative Analgesics Influence Breast Cancer Recurrence After Mastectomy? A Retrospective Analysis. Anesthesia & Analgesia. Ovid Technologies (Wolters Kluwer Health); 2010; 110:1630-1635 10.1213/ane.0b013e3181d2ad07
• Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study Cite
  Gierach GL, Lacey JV, Schatzkin A, Leitzmann MF, Richesson D, Hollenbeck AR, et al. Nonsteroidal anti-inflammatory drugs and breast cancer risk in the National Institutes of Health–AARP Diet and Health Study. Breast Cancer Research. Springer Science and Business Media LLC; 2008; 10 10.1186/bcr2089